PharmacoPlatform: Gateway ICSR ICH E2B(R3), Calcolo Sproporzionalità e Mining di Segnali di Sicurezza
PharmacoPlatform offre architetture software enterprise per la farmacovigilanza (PV), automatizzando l'acquisizione di segnalazioni ICSR, l'estrazione NLP di reazioni avverse e il rilevamento di segnali di sproporzione secondo gli standard FDA FAERS ed EMA EudraVigilance.
PharmacoPlatform Global Pharmacovigilance & Signal Detection Pipeline
Multichannel safety intake, MedDRA NLP normalization, and disproportionality scoring
Central System: Pharmacovigilance Core - E2B(R3) Engine & Disproportionality Analyzer
Clinical IoMT Nodes
- Multichannel Safety Intake Sink
- Clinical NLP / MedDRA Auto-Coder
- Individual Case Safety Report (ICSR) Core
- Disproportionality Signal Engine
- Regulatory Gateway Dispatcher
Architectural Layers & Regulatory Standards
- Multisource Adverse Event Ingestion (Optical Character Recognition (OCR) / Multi-Tenant Intake APIs): Ingesting adverse event reports from clinical trials, spontaneous patient hotlines, scientific literature, and social platforms.
- Medical Ontology Normalization (Clinical Transformer Models / MedDRA Dictionary v26+): Mapping unstructured patient symptom descriptions into standardized Medical Dictionary for Regulatory Activities (MedDRA) terms.
- Statistical Signal Detection & Disproportionality (Bayesian Confidence Propagation Neural Network (BCPNN)): Computing Proportional Reporting Ratios (PRR) and empirical Bayes geometric means to detect emerging safety signals.
- Automated Regulatory Electronic Submission (AS2 Secure Gateway / E2B(R3) XML Validator): Validating and transmitting expedited 7-day and 15-day safety reports to FDA FAERS and EudraVigilance.
Key Metrics: < 15 min (Automated ICSR Processing Time) | 99.4% (MedDRA Coding Accuracy) | 100% (ICH E2B(R3) XML Schema Compliance) | Real-Time (Adverse Signal Disproportionality Mining)
Farmacovigilanza automatizzata, segnalazione di sicurezza E2B(R3) e rilevamento di segnali di reazioni avverse ai farmaci (ADR)
Authoritative technical engineering reference for automated pharmacovigilance, e2b(r3) safety reporting & adverse drug reaction (adr) signal detection in FDA Premarket submissions, EU MDR, IEC 62304 Class C software lifecycle, ISO 13485 quality systems, and IoMT zero-trust interoperability.
Core Engineering Areas
Technical Articles
Related Cluster Architecture Specifications
- HealthVigilance — Zero-Trust IoMT Architecture, SaMD Risk Engineering & Autonomous Clinical Post-Market Vigilance
- AgenticSaMD — Autonomous Agentic Software as a Medical Device, Multi-Agent Clinical Decision Support & FDA GMLP Guardrails
- AITelemonitoring — Autonomous AI Telemonitoring, Virtual Nursing Assistants & Predictive Clinical Deterioration Scoring
- BCI2IoMT — Brain-Computer Interface IoMT Gateways, Neural Decoding & Electrophysiological Streaming